Autonomix Medical, Inc. expanded its Board of Directors from five to six members by appointing Sandra Kalter as an independent director effective September 14, 2026. Ms. Kalter brings over four decades of medical device industry experience, most recently serving as Vice President and Chief Regulatory Counsel at Medtronic plc, where she oversaw regulatory strategy for global operations and managed due diligence for more than 27 acquisitions. Her background includes significant involvement with major platforms such as renal denervation and electrophysiology technologies. She will participate in the company's standard compensation program for non-employee directors but has not been assigned to any specific committees at this time. Autonomix Medical, Inc. operates in the medical device industry, developing catheter-based microchip sensing arrays for nerve-targeted treatments.
